Author

Guillem Pons

Vall d'Hebron Institut de RecercaORCID 0000-0001-8128-740XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Gabriel Gallo-OlleriD· 2 shared Gabriela GuilléniD· 2 shared Josep M RomaiD· 2 shared Júlia Sansa-GironaiD· 2 shared Lia García-GilabertiD· 2 shared Lucas MorenoiD· 2 shared Miguel F. SeguraiD· 2 shared Natalia NavarroiD· 2 shared

Activity by Year

2024-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Gabriel Gallo-OllerORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintDec 3, 2024

Combined inhibition of MDM2 and PARP lead to a synergistic anti-tumoral response in p53 wild-type rhabdomyosarcoma models

Guillem Pons, Patricia Zarzosa, Gabriel Gallo-Oller…·Josep M Roma

This study shows that combining MDM2 and PARP inhibitors synergistically inhibits p53 wild-type rhabdomyosarcoma growth in vitro and in vivo.

DOI 10.1101/2024.12.03.626050

mousebulk RNA-seq

𝕏 PostBluesky

Cancer BiologyExperimental Hematology and OncologyPeer-reviewedApr 5, 2024

TRIB3 silencing promotes the downregulation of Akt pathway and PAX3-FOXO1 in high-risk rhabdomyosarcoma

Gabriel Gallo-Oller, Guillem Pons, Júlia Sansa-Girona…·Josep M Roma

This study shows TRIB3 silencing reduces Akt pathway activity and PAX3-FOXO1 levels in high-risk rhabdomyosarcoma, leading to decreased tumor growth and improved survival.

12 citations

humanbulk RNA-seq

𝕏 PostBluesky